Respiratory diseases drugs market covers drugs that are used in the treatment of a wide range of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic and acute bronchitis, emphysema and cystic fibrosis. Some of the major drugs in the market include antimuscarinics, corticosteroids, Codral, Coldrex and Lemsip.
Order report at
The global respiratory diseases drugs market has shown moderate growth in the past years with a CAGR of just over 6%. The year 2017 recorded highest ever market value in this industry as per TBRC’s inhouse consultants.
TBRC’s latest report show the historic and future trends in the market for each year with sourced reasons to support the growth claims.
The report also shows the respiratory diseases drugs market to grow at a much higher CAGR by 2021 as compared to 2017, along with geographies best suited for investments with highest return rate.
Download sample report at
China had the highest CAGR of more than 15% during 2013-2017; this country is expected to grow at the same CAGR by 2021. The highest historic growth was due to increase in tobacco smoking, air pollution levels and aging population in China and these factors are also expected to drive the respiratory drugs market in future. In 2016, China registered a total of 33.5 million cases of asthma, which is second highest in the world. In addition, China is ranked 5th on the global pollution index, and the air pollution levels are expected to rise in the forecast period thus increasing the cases of respiratory diseases.
TBRC’s latest report will cover in depth understanding and calculated impacts of each market factor on a global as well as regional level, to analyze the best investment strategy for this market.
Countries included in the report are GlaxosmithKline Plc, AstraZeneca Plc, Merck & Co, Novartis AG, and Johnson & Johnson.
About The Business Research Company.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on Linkedin: https://in.linkedin.com/company/the-business-research-company